Introduced 31/3/2000. Amended 30/9/2001, 24/10/2005.
Name of entity
J Medical Australia Limited
182.00 Rule 4.7B
1:#N 30 096 048 912
Consolidated statement of cash flows
Quarter ended ("current quarter")
I 3otl, June 2016
Current quarter Year to date Cash flows related to operating activities $A'ooo (12 months)
$A'ooo
1.1 Receipts from customers 3,215 14,074
1.2 Payments for (a) staff costs (603) (3,439)
advertising and marketing - -
research and development - -
leased assets (4) (34)
(e) inventory (1,812) (6,120)
(f) other working capital (683)(4,437)
1.3 Dividends received - -
Interest and other items of a similar nature
received --
Interest and other costs of finance paid - -
1.6 Income taxes refund (R&D tax refund) 23 49
1.7 Other (provide details if material) - -
Net operating cash flows 136 93
+ See chapter 19 for defined terms.
Appendix 4C Page 1
Current quarter $A'ooo | Year to date (12 months) $A'ooo | |
1.8 Net operating cash flows (carried forward) | 136 | 93 |
Cash flows related to investing activities | (45) | (398) |
Payment for acquisition of: | ||
(a) businesses (item 5) | ||
(b) equity investments | ||
(c) intellectual property | ||
(d) physical non-current assets | ||
(e) other non-current assets | ||
1.10 Proceeds from disposal of: | ||
(a) businesses (item s) | 39 | |
(b) equity investments | ||
(c) intellectual property | 135 | 135 |
(d) physical non-current assets | ||
(e) other non-current assets | ||
1.11 Loans to other entities | ||
1.12 Loans repaid by other entities | 46 | 46 |
1.13 Other (cash balance for acquired business) | ||
Net investing cash flows | 136 | (178) |
1.14 Total operating and investing cash flows | 272 | (85) |
Cash flows related to financing | ||
activities | ||
1.15 Proceeds from issues of shares, options, etc. | ||
1.16 Proceeds from sale o_f forfeited shares | ||
1.17 Proceeds from borrowings | ||
1.18 Repayment of borrowings | ||
1.19 Dividends paid | ||
1.20 Other (provide details if material) | ||
Net financing cash flows | ||
Net increase I (decrease) in cash held | 272 | (85) |
1.21 Cash at beginning of quarter/year to date | 608 | 982 |
1.22 Exchange rate adjustments | (1) | (18) |
1.2 Cash at end of Quarter | 879 | 879 |
+ See chapter 19 for defined terms. Appendix 4C Page 2
Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entitiesCurrent quarter
$A'ooo
1.24 Aggregate amount of payments to the parties included in item 1.2 48
1.25 Aggregate amount of loans to the parties included in item 1.11 -
1.26 Explanation necessary for an understanding of the transactions ($A'ooo)
Directors Fees Professional Fees (Company Secretarial) | 37 11 |
48 |
2.1 Details of financing and investing transactions which have had a material effect on
consolidated assets and liabilities but did not involve cash flows
NIA
2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest
I N/A
Financing facilities availableAdd notes as necessaryfor an understanding of the position. (See AASB 1026 paragra ph 12.2).
Amount available $A'ooo | Amount used $A'ooo |
- | - |
- | - |
- | - |
Loan facilities
Credit standby arrangements
Bank Overdraft
+ See chapter 19 for defined terms.
Appendix 4C Page 3
Reconciliation of cash
Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows. | Current quarter $.A'ooo | Previous quarter $A'ooo |
| 829 | 558 |
- | - | |
- | - | |
50 | 50 | |
Total: cash at end of quarter (item 1.23) | 879 | 608 |
Acquisitions and disposals of business entities
Acquisitions $.A'ooo (Item 1.q(a)) | Disposals $.A'ooo (Item 1.10(a)) |
5.1 Name of entity
Place of
5·2 incorporation or registration Consideration (net of
5·3 cash in entity) for
disposal
5·4 Total net assets
5·5 Nature of business
Compliance statement
1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.
2 ./This s/ta_J;errr does give a tr,u:e -an.d·_f:ai1!-view-0f:the.
Sr ···" " ............................................................. Date: 28 July 2016
·· ···· (Director/Company secretary)
Print name: Ian Mitchell
Notes
+ See chapter 19 for defined terms. Appendix 4C Page 4
Medical Australia Limited published this content on 29 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 July 2016 23:06:03 UTC.
Original documenthttp://www.medaust.com/irm/PDF/1511/Appendix4Cquarterly
Public permalinkhttp://www.publicnow.com/view/871EB36EAF319AA25D4D2609BFD222D1528F0735